Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services Limited, has received a suspension order for a Drug License from the Asst. Commissioner & Licensing authority, Food & Drug Administrations, MH, Nashik. The suspension is for five days affecting a store situated at Samta Nagar Nashik, Maharashtra. The action was taken under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The order was received on May 6, 2026. The company has quantified the potential revenue loss at Rs 0.75 lakhs.
The suspension affects only one store for a short period with a small estimated revenue impact of Rs 0.75 lakhs, indicating minimal disruption to overall operations.